GS
Insider selling
Gaurav Shah sold $172K of Rocket Pharmaceuticals, Inc. (RCKT) stock
Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc. (RCKT), sold 55,684 shares of RCKT stock worth $172K, per an SEC Form 4 filed May 26, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 21, 2026, 5 days before it was made public.
RCKT has moved +5.1% since the trade date, from $3.11 to $3.27 (Sep 21, 2026 close).
- Traded
- May 21, 2026
- Disclosed
- May 26, 2026
- Filing delay
- 5 days
- Price since
- +5.1%
- Role
- CEO
- Source
- SEC Form 4
More RCKT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.